Single‐cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID‐19 infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single‐cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID‐19 infection
Authors
Keywords
-
Journal
Molecular Genetics & Genomic Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-03
DOI
10.1002/mgg3.1442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
- (2020) Xiao-Wei Xu et al. BMJ-British Medical Journal
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Single-cell RNA sequencing of human kidney
- (2020) Jinling Liao et al. Scientific Data
- Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats
- (2019) Nisha Sharma et al. LIFE SCIENCES
- PBMC fixation and processing for Chromium single-cell RNA sequencing
- (2018) Jinguo Chen et al. Journal of Translational Medicine
- Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease
- (2018) Jihwan Park et al. SCIENCE
- Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
- (2018) Matthew D. Young et al. SCIENCE
- Fiend and friend in the renin angiotensin system: An insight on acute kidney injury
- (2018) Nisha Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular mechanisms of ROS production and oxidative stress in diabetes
- (2016) P. Newsholme et al. BIOCHEMICAL JOURNAL
- Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
- (2016) Luigi Gnudi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2
- (2016) Man-Lung Yeung et al. Nature Microbiology
- Renal Hemodynamics in AKI: In Search of New Treatment Targets
- (2015) M. Matejovic et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes
- (2015) J. W. Lee et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Kidney Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling
- (2015) Masato Habuka et al. PLoS One
- The emergence of the glomerular parietal epithelial cell
- (2014) Stuart J. Shankland et al. Nature Reviews Nephrology
- A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)
- (2012) Frans Van de Werf et al. AMERICAN HEART JOURNAL
- Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
- (2009) G. Y. Oudit et al. DIABETES
- Angiotensin-converting enzyme 2 and the kidney
- (2008) Maria Jose Soler et al. EXPERIMENTAL PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now